mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
6e-07 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-07 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
6e-07 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
7e-07 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
7e-07 |
mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
9e-07 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
1e-06 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-06 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
0.23 |
2e-06 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
3e-06 |